WeVote

Bill

Bill

S 2891

Prohibits certain steering and marketing practices involving dispensing of prescription drugs and drug samples.

2026-2027 Regular Session Introduced by Vin Gopal and 1 co-sponsor

New Jersey bill prohibits pharmaceutical steering and deceptive marketing practices designed to influence prescription drug and pharmacy selection away from patient interests.

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
0
WeVote Research Nonpartisan
Bill Summary · S 2891

Legislative bill overview

S 2891 prohibits pharmaceutical companies and healthcare providers from using deceptive steering and marketing practices to influence which prescription drugs patients receive or which pharmacies they use. The bill also restricts the distribution and promotion of drug samples in ways designed to manipulate patient choice rather than provide legitimate therapeutic samples.

Why is this important

Steering practices can inflate medication costs for patients and insurers by directing people toward more expensive drugs regardless of clinical need or affordability. Restricting these practices aims to ensure prescribing decisions are based on medical appropriateness and patient benefit rather than manufacturer incentives or marketing pressure.

Potential points of contention

  • Industry opposition: Pharmaceutical manufacturers and pharmacy benefit managers may argue the bill restricts legitimate marketing and sampling programs that inform healthcare providers about new treatment options
  • Definition clarity: The bill's language on what constitutes prohibited "steering" versus permissible promotion may be ambiguous, creating compliance uncertainty and potential litigation over interpretation
  • Implementation challenges: Enforcing restrictions on marketing practices across multiple stakeholders (manufacturers, insurers, pharmacies, providers) could prove difficult without clear regulatory guidance and adequate oversight resources

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.